Hypertension and diabetes, but not leptin and adiponectin, mediate the relationship between body fat and chronic kidney disease.
Adiponectin
Diabetes
Hypertension
Kidney
Leptin
Obesity
Journal
Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444
Informations de publication
Date de publication:
16 Apr 2024
16 Apr 2024
Historique:
received:
14
12
2023
accepted:
28
03
2024
medline:
17
4
2024
pubmed:
17
4
2024
entrez:
16
4
2024
Statut:
aheadofprint
Résumé
Obesity may promote kidney damage through hemodynamic and hormonal effects. We investigated the association between body mass index (BMI), total body fat (TBF) and chronic kidney disease (CKD) and whether hypertension, diabetes, leptin and adiponectin mediated these associations. In this cross-sectional analysis of the Netherlands Epidemiology of Obesity study, 6671 participants (45-65 y) were included. We defined CKD as eGFR <60 ml/min/1.73 m At baseline mean (SD) age was 56 (6), BMI 26.3 (4.4), 44% men, and 4% had CKD. Higher BMI and TBF were associated with 1.08 (95%CI 1.05; 1.11) and 1.05-fold (95%CI 1.02; 1.08) increased odds of CKD, respectively. As adiponectin was not associated with any of the outcomes, it was not studied further as a mediating factor. The association between BMI and CKD was 8.5% (95%CI 0.5; 16.5) mediated by diabetes and 22.3% (95%CI 7.5; 37.2) by hypertension. In addition, the association between TBF and CKD was 9.6% (95%CI -0.4; 19.6) mediated by diabetes and 22.4% (95%CI 4.2; 40.6) by hypertension. We could not confirm mediation by leptin in the association between BMI and CKD (35.6% [95%CI -18.8; 90.3]), nor between TBF and CKD (59.7% [95%CI -7.1; 126.6]). Our results suggest that the relations between BMI, TBF and CKD are in part mediated by diabetes and hypertension.
Identifiants
pubmed: 38627329
doi: 10.1007/s12020-024-03811-6
pii: 10.1007/s12020-024-03811-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
World Health Organization. Obesity and overweight. 2018 [cited 2019 May 16]; Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight .
World Health Organization. Obesity. 2014 [cited 2019 May 22]; Available from: https://www.who.int/topics/obesity/en/ .
GBD 2015 Obesity Collaborators, Health effects of overweight and obesity in 195 countries over 25 years. N. Engl. J. Med. 377(1), 13–27 (2017).
doi: 10.1056/NEJMoa1614362
E.K. Hoogeveen et al. Obesity and mortality risk among younger dialysis patients. Clin. J. Am. Soc. Nephrol. 7(2), 280–288 (2012).
pubmed: 22223612
pmcid: 3280032
doi: 10.2215/CJN.05700611
N.R. Hill et al. Global prevalence of chronic kidney disease—a systematic review and meta-analysis. PLoS One 11(7), e0158765 (2016).
pubmed: 27383068
pmcid: 4934905
doi: 10.1371/journal.pone.0158765
K. Bruck et al. CKD prevalence varies across the European general population. J. Am. Soc. Nephrol. 27(7), 2135–2147 (2016).
pubmed: 26701975
doi: 10.1681/ASN.2015050542
E.K. Hoogeveen et al. Kidney function and specific mortality in 60-80 years old post-myocardial infarction patients: a 10-year follow-up study. PLoS One 12, e0171868 (2017).
pubmed: 28182761
pmcid: 5300181
doi: 10.1371/journal.pone.0171868
J. Coresh et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311(24), 2518–2531 (2014).
pubmed: 24892770
pmcid: 4172342
doi: 10.1001/jama.2014.6634
A.E. Decleves, K. Sharma, Obesity and kidney disease: differential effects of obesity on adipose tissue and kidney inflammation and fibrosis. Curr. Opin. Nephrol. Hypertens. 24(1), 28–36 (2015).
pubmed: 25470014
pmcid: 4847436
doi: 10.1097/MNH.0000000000000087
C.P. Kovesdy et al. Obesity and kidney disease: hidden consequences of the epidemic. Can. J. Kidney Health Dis. 4, 2054358117698669 (2017).
pubmed: 28540059
pmcid: 5433675
doi: 10.1177/2054358117698669
M. Praga, Obesity-a neglected culprit in renal disease. Nephrol. Dial. Transplant. 17(7), 1157–1159 (2002).
pubmed: 12105233
doi: 10.1093/ndt/17.7.1157
I.A. Dekkers et al. The separate contributions of visceral fat and liver fat to chronic kidney disease-related renal outcomes. J. Ren. Nutr. 30(4), 286–295 (2020).
pubmed: 31668939
doi: 10.1053/j.jrn.2019.09.002
T.W. Elffers et al. Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese women. PLoS One 12(9), e0185403 (2017).
pubmed: 28957363
pmcid: 5619737
doi: 10.1371/journal.pone.0185403
T. Christen et al. The role of inflammation in the association between overall and visceral adiposity and subclinical atherosclerosis. Nutr. Metab. Cardiovasc. Dis. 29(7), 728–735 (2019).
pubmed: 31138500
doi: 10.1016/j.numecd.2019.03.010
T. Thethi, M. Kamiyama, H. Kobori, The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome. Curr. Hypertens. Rep. 14(2), 160–169 (2012).
pubmed: 22302531
pmcid: 3337881
doi: 10.1007/s11906-012-0245-z
R. de Mutsert et al. The Netherlands Epidemiology of Obesity (NEO) study: study design and data collection. Eur. J. Epidemiol. 28(6), 513–523 (2013).
pubmed: 23576214
doi: 10.1007/s10654-013-9801-3
E. Siebelink, A. Geelen, J.H. de Vries, Self-reported energy intake by FFQ compared with actual energy intake to maintain body weight in 516 adults. Br. J. Nutr. 106(2), 274–281 (2011).
pubmed: 21338536
doi: 10.1017/S0007114511000067
A.C. Verkleij-Hagoort et al. Validation of the assessment of folate and vitamin B12 intake in women of reproductive age: the method of triads. Eur. J. Clin. Nutr. 61(5), 610–615 (2007).
pubmed: 17164826
doi: 10.1038/sj.ejcn.1602581
M. Looman et al. Development and evaluation of the Dutch Healthy Diet Index 2015. Public Health Nutr. 20(13), 2289–2299 (2017).
pubmed: 28625202
pmcid: 10261559
doi: 10.1017/S136898001700091X
G.C. Wendel-Vos et al. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J. Clin. Epidemiol. 56(12), 1163–1169 (2003).
pubmed: 14680666
doi: 10.1016/S0895-4356(03)00220-8
E.L. de Hollander et al. The SQUASH was a more valid tool than the OBiN for categorizing adults according to the Dutch physical activity and the combined guideline. J. Clin. Epidemiol. 65(1), 73–81 (2012).
pubmed: 21840174
doi: 10.1016/j.jclinepi.2011.05.005
T. Christen et al. Sex differences in body fat distribution are related to sex differences in serum leptin and adiponectin. Peptides 107, 25–31 (2018).
pubmed: 30076861
doi: 10.1016/j.peptides.2018.07.008
L.A. Inker et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N. Engl. J. Med. 367(1), 20–29 (2012).
pubmed: 22762315
pmcid: 4398023
doi: 10.1056/NEJMoa1114248
T.I. Justesen et al. Albumin-to-creatinine ratio in random urine samples might replace 24-h urine collections in screening for micro- and macroalbuminuria in pregnant woman with type 1 diabetes. Diabetes Care 29(4), 924–925 (2006).
pubmed: 16567839
doi: 10.2337/diacare.29.04.06.dc06-1555
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl. 3(1), 1–150 (2013).
E.L. Korn, B.I. Graubard, Epidemiologic studies utilizing surveys: accounting for the sampling design. Am. J. Public Health 81(9), 1166–1173 (1991).
pubmed: 1951829
pmcid: 1405642
doi: 10.2105/AJPH.81.9.1166
T. Lumley, Analysis of complex survey samples. J. Stat. Softw. 9(8), 1–19 (2004).
doi: 10.18637/jss.v009.i08
Nederland de Maat Genomen. 2012 2 November 2018 [cited 2021 20 September]; Available from: https://www.rivm.nl/nederland-maat-genomen .
R.M. Baron, D.A. Kenny, The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Personal. Soc. Psychol. 51(6), 1173–1182 (1986).
doi: 10.1037/0022-3514.51.6.1173
D. Gunzler et al. Introduction to mediation analysis with structural equation modeling. Shanghai Arch. Psychiatry 25(6), 390–394 (2013).
pubmed: 24991183
pmcid: 4054581
A.H. Smith, M.N. Bates, Confidence limit analyses should replace power calculations in the interpretation of epidemiologic studies. Epidemiology 3(5), 449–452 (1992).
pubmed: 1391138
doi: 10.1097/00001648-199209000-00011
S.N. Goodman, J.A. Berlin, The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann. Intern. Med. 121(3), 200–206 (1994).
pubmed: 8017747
doi: 10.7326/0003-4819-121-3-199408010-00008
K. Esmeijer et al. Body-fat indicators and kidney function decline in older post-myocardial infarction patients: The Alpha Omega Cohort Study. Eur. J. Prev. Cardiol. 25(1), 90–99 (2018).
pubmed: 29095051
doi: 10.1177/2047487317739986
Fund, A.K. Stages of kidney disease. 2021 22-11-2021 [cited 2022 30-09]; Available from: https://www.kidneyfund.org/all-about-kidneys/stages-kidney-disease .
R.G. Nelson et al. Development of risk prediction equations for incident chronic kidney disease. JAMA 322(21), 2104–2114 (2019).
pubmed: 31703124
pmcid: 6865298
doi: 10.1001/jama.2019.17379
L. Mulyadi et al. Body fat distribution and total body fat as risk factors for microalbuminuria in the obese. Ann. Nutr. Metab. 45(2), 67–71 (2001).
pubmed: 11359031
doi: 10.1159/000046708
W.Y. Lin et al. Central obesity and albuminuria: both cross-sectional and longitudinal studies in Chinese. PLoS One 7(12), e47960 (2012).
pubmed: 23251329
pmcid: 3520991
doi: 10.1371/journal.pone.0047960
E.K. Hoogeveen, The epidemiology of diabetic kidney disease. Kidney Dial. 2, 433–442 (2022).
doi: 10.3390/kidneydial2030038
K.M. Pantalone et al. Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system. BMJ Open 7(11), e017583 (2017).
pubmed: 29150468
pmcid: 5702021
doi: 10.1136/bmjopen-2017-017583
J. Przybycinski et al. Adiponectin in chronic kidney disease. Int. J. Mol. Sci. 21(24), 9375 (2020)
pubmed: 33317050
pmcid: 7764041
doi: 10.3390/ijms21249375
S. Nakamaki et al. Adiponectin reduces proteinuria in streptozotocin-induced diabetic Wistar rats. Exp. Biol. Med. 236(5), 614–620 (2011).
doi: 10.1258/ebm.2011.010218
H. Kobayashi et al. Adiponectin is not associated with renal function decline in community-dwelling elderly adults. Medicine 97(21), e10847 (2018).
pubmed: 29794781
pmcid: 6392687
doi: 10.1097/MD.0000000000010847
G. Wolf et al. Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments]. Kidney Int. 56(3), 860–872 (1999).
pubmed: 10469355
doi: 10.1046/j.1523-1755.1999.00626.x
S. Mao et al. Leptin and chronic kidney diseases. J. Recept. Signal Transduct. Res. 38(2), 89–94 (2018).
pubmed: 29388492
doi: 10.1080/10799893.2018.1431278
G. Wolf et al. Leptin and renal disease. Am. J. Kidney Dis. 39(1), 1–11 (2002).
pubmed: 11774095
doi: 10.1053/ajkd.2002.29865
J.M. Friedman, Leptin and the regulation of body weigh. Keio J. Med. 60(1), 1–9 (2011).
pubmed: 21460597
doi: 10.2302/kjm.60.1